The effect of oral Mycobacterium vaccae on subsequent responses of mice to BCG sensitization
- PMID: 4082281
- DOI: 10.1016/0041-3879(85)90062-5
The effect of oral Mycobacterium vaccae on subsequent responses of mice to BCG sensitization
Abstract
It has been postulated that previous exposure to mycobacteria in the environment may be a contributing factor to the variable efficacy of BCG vaccination in protecting against human tuberculosis or leprosy, in different geographical regions. To test this hypothesis mice were given Mycobacterium vaccae in their drinking water for 3 weeks immediately, 27 days, or 54 days before they were injected subcutaneously with BCG. Spleen cells were examined, 50 days after injection of the mice, for ability to proliferate in vitro in response to killed mycobacteria added to the cultures. The results show that, depending on the timing of the exposure of the mice in vivo to M. vaccae before BCG injection and the dose of the mycobacterial challenge in vitro, oral administration of this species of environmental mycobacteria can either enhance, mask or interfere with the expression of sensitization by BCG. Thus, our data from mice support the hypothesis that the results of BCG vaccination for a particular human population are influenced by exposure to indigenous mycobacteria.
Similar articles
-
Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens.Infect Immun. 2005 Apr;73(4):2190-6. doi: 10.1128/IAI.73.4.2190-2196.2005. Infect Immun. 2005. PMID: 15784562 Free PMC article.
-
Comparative study of immunizing and delayed hypersensitivity eliciting antigens of Mycobacterium leprae, M. tuberculosis, M. vaccae, and M. bovis (BCG).Int J Lepr Other Mycobact Dis. 1987 Mar;55(1):42-53. Int J Lepr Other Mycobact Dis. 1987. PMID: 2435824
-
Increased protection against bovine tuberculosis in the brushtail possum (Trichosurus vulpecula) when BCG is administered with killed Mycobacterium vaccae.Tuberculosis (Edinb). 2002;82(1):15-22. doi: 10.1054/tube.2001.0318. Tuberculosis (Edinb). 2002. PMID: 11914058
-
Improving on BCG.APMIS. 1991 Feb;99(2):103-13. doi: 10.1111/j.1699-0463.1991.tb05127.x. APMIS. 1991. PMID: 2001276 Review.
-
Original Mycobacterial Sin, a consequence of highly homologous antigens?Vet Microbiol. 2017 May;203:286-293. doi: 10.1016/j.vetmic.2017.03.028. Epub 2017 Mar 27. Vet Microbiol. 2017. PMID: 28619159 Review.
Cited by
-
AIDS-related mycobacterial disease.Springer Semin Immunopathol. 1988;10(4):375-91. doi: 10.1007/BF02053847. Springer Semin Immunopathol. 1988. PMID: 3065953 Review. No abstract available.
-
Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome.Clin Microbiol Rev. 1989 Oct;2(4):360-77. doi: 10.1128/CMR.2.4.360. Clin Microbiol Rev. 1989. PMID: 2680057 Free PMC article. Review.
-
Effects of non-tuberculous mycobacteria on BCG vaccine efficacy: A narrative review.J Clin Tuberc Other Mycobact Dis. 2024 May 4;36:100451. doi: 10.1016/j.jctube.2024.100451. eCollection 2024 Aug. J Clin Tuberc Other Mycobact Dis. 2024. PMID: 38764556 Free PMC article. Review.
-
Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis.Infect Immun. 2002 Feb;70(2):672-8. doi: 10.1128/IAI.70.2.672-678.2002. Infect Immun. 2002. PMID: 11796598 Free PMC article.
-
Vaccines for TB: Lessons from the Past Translating into Future Potentials.J Immunol Res. 2015;2015:916780. doi: 10.1155/2015/916780. Epub 2015 Jun 3. J Immunol Res. 2015. PMID: 26146643 Free PMC article. Review.